← Back to screener

EXELIXIS, INC. EXEL

Rank #1717 · Nasdaq · $17.4B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
43.7
P/E
83.9
P/B
7.01
ROE
8.3%
Op. Margin
9.3%
Debt Ratio
28%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Weak

P/E 83.9x, P/B 7.01x. Ranks in the top 66% of the universe.

Profitability ★★★☆☆
Average

ROE 8.3%. Ranks in the top 48% of the universe.

Safety ★★★★☆
Excellent

Debt ratio 28%. Ranks in the top 16% of the universe. Under 100% is generally considered a safe level.

Growth ★★★★☆
Good

Revenue growth of 13.6% year over year. Ranks in the top 27% of the universe.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011$0.2B$-0.1B$-0.1B$-0.1B-80.3-1047
2012$0.2B$-0.1B$-0.1B$-0.2B-49.4-185
2013$0.3B$0.1B$0.1B$-0.2B30.9-186
2014$0.0B$-0.1B$-0.1B$0.1B-258.0482
2015$0.0B$-0.2B$-0.2B$0.3B-640.5148
2016$0.0B$-0.2B$-0.1B$0.2B-893.9200
2017$0.0B$-0.1B$-0.2B$-0.2B-326.6-318
2018$0.2B$-0.0B$-0.1B$-0.1B-14.7-263
2019$0.5B$0.2B$0.2B$0.1B36.7151
2020$0.9B$0.4B$0.7B$0.3B51.470
2021$1.0B$0.4B$0.3B$1.3B38.220
2022$1.0B$0.1B$0.1B$1.7B11.124
2023$1.4B$0.3B$0.2B$1.9B20.031
2024$1.6B$0.2B$0.2B$2.2B12.531
2025$1.8B$0.2B$0.2B$2.5B9.328

← See the full screener